Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF

Авторы
Senni M. 1 , Wachter R. 2 , Belohlavek J. 3 , Witte K. 4 , Strabuzynska-Migaj E. 5 , Kobalava Z. 6 , Fonseca C. 7 , Noe A. 8 , Butylin D. 8 , Schwende H. 8 , Pascual-Figal D. 9
Журнал
European Heart Journal
Язык
Английский
Страницы
1392-1393
Статус
Опубликовано
Том
39
Год
2018
Организации
  • 1 Osped Papa Giovanni XXIII, Heart Failure & Transplant Unit, Bergamo, Italy
  • 2 Leipzig Univ Hosp, Clin & Policlin Cardiol, Leipzig, Germany
  • 3 Charles Univ Prague, Prague, Czech Republic
  • 4 Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England
  • 5 Poznan Univ Med Sci, Dept Cardiol 1, Poznan, Poland
  • 6 Peoples Friendship Univ Russia RUDN Univ, Moscow, Russia
  • 7 Hosp Sao Francisco Xavier, CHLO, Heart Failure Unit, Dept Internal Med, Lisbon, Portugal
  • 8 Novartis Pharma AG, Basel, Switzerland
  • 9 Hosp Clin Univ Virgen de la Arrixaca, Dept Cardiol, Murcia, Spain
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи